Zwischenprodukte für N-(3-(7H-PYRROLO[2,3-D]pyrimidin-4-Yl)phenyl)benzamid-Derivate

Details

Veröffentlichungs-Nr.

EP4755462

Anmeldetag

22. März 2019

Veröffentlichung

10. Juni 2026

Rechtsraum

EP

IPC

A61P37/00

Abstract

The invention relates to compounds of the formula (I) <img class="EMIRef" id="387e60f0-aacf-4316-b6d9-42265eac5e26-ia01" /> or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined in the specification; to intermediates in the preparation of the compounds, to pharmaceutical compositions comprising the compounds and to use of the compounds in the treatment of disease.

Anmelder

Firma

Novartis AG

Land

🇨🇭 Schweiz